Docket Room.
SB 1795·MO·senate

Creates provisions relating to biomarker testing

FailedFiled Feb 26, 2026
Sponsor: Stephen Webber (D)
Latest Action

Second Read and Referred S Families, Seniors and Health Committee

May 7, 2026

Email me when SB 1795 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SB 1795. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill directs the state Medicaid program (MO HealthNet) to pay for biomarker testing when it has proven clinical utility, and it obligates private insurers, nonprofit plans, and HMOs that issue contracts after August 28 2026 to do the same. It also sets up an easy‑to‑use exception process and limits the need for multiple biopsies. The measure does not require coverage for screening tests.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SB 1795

3 free questions a day, no account

History

  1. Second Read and Referred S Families, Seniors and Health Committee
  2. S First Read

Sponsors

  • Stephen Webber (D) · sponsor
  • Webber, Stephen

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SB 1795 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SB 1795 free

Or ask your AI assistant about SB 1795 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice